| Gene symbol | EPHA2 | Synonyms | ARCC2, CTPA, CTPP1, CTRCT6, ECK | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.13 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | EPH receptor A2 | ||||
| GTO ID | GTC3252 |
| Trial ID | NCT05631886 |
| Disease | Lymphoma |
| Altered gene | EPHA2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-DC cell |
| Treatment | TP53-EphA-2-CAR-DC |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Combination of CAR-DC Vaccine and Anti-PD-1 Antibody in Malignant Tumors |
| Year | 2022 |
| Country | China |
| Company sponsor | Chinese PLA General Hospital |
| Other ID(s) | CHN-PLAGH-BT-075 |
| Cohort 1 | |||||||||||||
|
|||||||||||||